FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bupivacaine Hydrochloride Injection, USP
Status: Currently in Shortage
»Date first posted: 02/20/2018
»Therapeutic Categories: Anesthesia

Expand all

Areva Pharmaceuticals, Inc. (New 09/12/2019)

Company Contact Information:
812-399-3599, Option # 1

Presentation	Availability and Estimated Shortage Duration	Related Information
0.25% 5 mL single-dose ampules (NDC 59923-717-05)	Available	Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage. Importation will begin mid-September 2019. Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers. Please call Areva Pharmaceutical Customer Service at 812-399-3599, Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments. Dear Health Care Provider Letter
0.25% 10 mL single-dose ampules (NDC 59923-719-10)	Available	Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage. Importation will begin mid-September 2019. Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers. Please call Areva Pharmaceutical Customer Service at 812-399-3599, Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments. Dear Health Care Provider Letter
0.5% 5 mL single-dose ampules (NDC 59923-718-05)	Available	Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage. Importation will begin mid-September 2019. Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers. Please call Areva Pharmaceutical Customer Service at 812-399-3599, Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments. Dear Health Care Provider Letter
0.5% 10 mL single-dose ampules (NDC 59923-720-10)	Available	Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage. Importation will begin mid-September 2019. Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers. Please call Areva Pharmaceutical Customer Service at 812-399-3599, Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments. Dear Health Care Provider Letter

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 02/19/2021)

Company Contact Information:
888-238-7880

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.25% 10 mL Single Dose Vials (NDC 55150-167-10)	Available	Check wholesalers for inventory	Demand increase for the drug
0.25% 30 mL Single Dose Vials (NDC 55150-168-30)	Available	Check wholesalers for inventory	Demand increase for the drug
0.5% 10 mL Single Dose Vials (NDC 55150-169-10)	Available	Check wholesalers for inventory	Demand increase for the drug
0.5% 30 mL Single Dose Vials (NDC 55150-170-30)	Available	Check wholesalers for inventory	Demand increase for the drug
0.75% 10 mL Single Dose Vials (NDC 55150-171-10)	Available	Check wholesalers for inventory	Demand increase for the drug
0.75% 30 mL Single Dose Vials (NDC 55150-172-30)	Available	Check wholesalers for inventory	Demand increase for the drug
0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50)	Available	Check wholesaler for inventory	Demand increase for the drug
0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50)	Currently on backorder - next shipment anticipated Apr 21	Sporadic availability expected.	Demand increase for the drug

Baxter Healthcare (Reverified 01/27/2021)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Bupivacaine Spinal, USP (7.5 mg/mL in 8.25% dextrose) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)	Stocked out - recovery TBD	SPINAL 0.75% - Sterile Hyperbaric Solution for Spinal Anesthesia	Manufacturing Delay

Fresenius Kabi USA, LLC (Revised 02/16/2021)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-467-57)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-17)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)	Backordered. Next release March 2021.	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-464-31)	Backordered. Next release date not available at this time.	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-17)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-37)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-466-31)	Backordered. Next release date not available at this time.		Demand increase for the drug
Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-17)	Available	Check wholesalers for inventory.	Demand increase for the drug
Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-37)	Available	Check wholesalers for inventory.	Demand increase for the drug

Hospira, Inc. (Revised 02/23/2021)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01)	Limited Supply Available. Next Delivery and Estimated Recovery: March 2021	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Demand increase for the drug
75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02)	Next Delivery: March 2021; Estimated Recovery: June 2021	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Demand increase for the drug
125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01)	Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: June 2021	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Demand increase for the drug
75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409-3613-01)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other
Marcaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409- 1761-02)	Available	Dear Customer Letter - Supply Update of Earlier Delivery Dates	Other